Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 290 of 6351
-
Can a slow start with CBD oil tame Hard-to-Control seizures?
Disease control Not yet recruitingThis is a Phase 3b/Phase 4 study. The purpose of this study is to learn more about the efficacy of using CBD-OS as an add-on therapy for the treatment of LGS in adults.
Phase 4 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Family support may curb obesity risk in children of mothers with gestational diabetes
Prevention Not yet recruitingGestational diabetes mellitus (GDM) is associated with an increased risk of childhood obesity and other adverse health outcomes. Early-life nutrition, particularly exclusive breastfeeding, plays an important role in reducing this risk. In Vietnam, infant feeding and childcare pra…
Sponsor: Thai Binh University of Medicine and Pharmacy • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Can a weekly injection melt fat hiding in the pancreas?
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled, parallel-group, single-center clinical trial designed to evaluate the efficacy and safety of mazdutide in improving fatty pancreas in patients with overweight or obesity. The study plans to enroll 194 participants with overw…
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for advanced melanoma: immunotherapy combo tested in india
Disease control Not yet recruitingThe purpose of this study is to assess the safety and tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) in unresectable or metastatic melanoma participants in India.
Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Gamified ear-brain workout may sharpen hearing in older age
Symptom relief Not yet recruitingAbstract Objectives To assess the effectiveness of a web-based gamified auditory-cognitive dual-task training (ACDT) in improving the everyday listening abilities of older adults with hearing loss (HL), including speech perception performance, cognition, and self-reported hearing…
Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Can a drug duo prime the brain to fight aggressive tumors?
Disease control Not yet recruitingThis clinical trial is designed with two treatment stages: Stage 1: one cycle of study drug treatment prior to initiation of first-line standard radiation in all study participants. Stage 2: two additional cycles of study drug treatment (8 weeks total) concomitantly with standard…
Early phase 1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Laser precision: new device aims to clear heart blockages before stenting
Disease control Not yet recruitingThis prospective, multi-center clinical trial evaluates the safety and efficacy of the Coronary Laser Atherectomy System for the pretreatment of coronary artery stenosis. The study consists of two phases: a first-in-human (FIM) phase enrolling 5 subjects in a single center, and a…
Sponsor: Shanghai MicroPort Rhythm MedTech Co., Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can adding immunotherapy to standard cancer care be safe for indian patients?
Disease control Not yet recruitingThe goal of this study is to assess the safety of pembrolizumab with chemotherapy or chemoradiotherapy in participants in India for: * Advanced gastric or gastroesophageal junction \[GEJ\] cancer that is (human epidermal growth factor receptor 2 \[HER2\]-negative and has a progr…
Phase 4 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a Once-Weekly shot tame type 2 diabetes blood sugar?
Disease control Not yet recruitingThis study is a multicenter, randomized, double-blind, placebo and active-controlled, dose-finding phase 2 study aimed to evaluate the efficacy, safety, pharmacokinetics (PK) and immunogenicity of SYH2069 Injection in participants with Type 2 Diabetes Mellitus (T2DM) inadequate g…
Phase 2 • Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can Long-Term tucatinib use remain safe for HER2-Positive cancers?
Disease control Not yet recruitingThe purpose of this protocol is to give continued access to tucatinib eligible participants. It also enables ongoing safety follow-up for those who continue to benefit from the study treatment. These participants were part of Pfizer-sponsored tucatinib parent studies that will be…
Phase 4 • Sponsor: Pfizer • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Could extended CPAP save preterm Babies' lungs?
Disease control Recruiting nowThe objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.
Sponsor: NICHD Neonatal Research Network • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Psilocybin trial aims to shield cancer patients from chemo nerve pain
Prevention Not yet recruitingTo learn if psilocybin can help to prevent or decrease the severity of chemotherapy-induced peripheral neuropathy (CIPN) in patients who are receiving chemotherapy for the treatment of breast, colorectal, and In this study, psilocybin is being compared to standard supportive care…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC
-
New vaccine combo aims to slow Alzheimer's by targeting tau tangles
Disease control By invitation onlyThe Alzheimer's Tau Platform (ATP) is a multi-center platform trial to evaluate the safety and effectiveness of tau-directed therapies, alone or in combination with donanemab, in adults aged 50-80 with late preclinical or early prodromal Alzheimer's disease. Regimen A will evalu…
Phase 2 • Sponsor: Paul S. Aisen • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Brain training app could be key to stroke recovery and return to work
Symptom relief Not yet recruitingStroke can damage the brain, which may make it harder for survivors to think clearly, solve problems, and remember things. These changes in thinking can make it difficult for people to return to their jobs after a stroke. More and more, people are using computer-based exercises i…
Sponsor: Bournemouth University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
A personalized support system aims to close cancer care gaps for hispanic patients
Disease control Not yet recruitingThis is a randomized controlled, type 1 hybrid effectiveness-implementation trial to evaluate the effectiveness of a patient-reported outcomes (PRO)-driven culturally grounded supportive care navigation in reducing healthcare disparities among Hispanic/Latinx patients receiving a…
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Breathing in a special gas: a new MRI lens on lung fibrosis treatment
Knowledge-focused Not yet recruitingThe goal of this observational study is to better understand how treatment affects the lungs of adults (ages 18-80) with fibrotic interstitial lung diseases. The main questions it aims to answer are: * Can advanced imaging detect the effect of currently approved therapies on peo…
Sponsor: Dr. Grace Parraga • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
A new exercise for the eyes: could it restore 3D vision?
Disease control Not yet recruitingThis study evaluates a novel attention-based binocular visual search training paradigm designed to improve stereopsis (stereo vision) in individuals with impaired binocular vision. Disruptions in balanced binocular input, such as from strabismus or anisometropia, often lead to de…
Sponsor: Centre for Eye and Vision Research • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New personalized vaccine takes on tough cancers
Disease control Not yet recruitingThis is a phase 1, open-label, multicentric study evaluating the safety, feasibility and efficacy of ODI-2001, a personnalized therapeutic cancer vaccine composed of DNA neoantigen vaccine, Modified Vaccinia virus Ankara (MVA) viral adjuvant and anti-CTLA4 (ipilimumab), in patien…
Phase 1 • Sponsor: Centre Georges Francois Leclerc • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Weight-loss shot plus IUD may help reverse womb cancer without surgery
Disease control Not yet recruitingThis phase II trial studies whether adding tirzepatide injections to a levonorgestrel intrauterine device (LNG-IUD) improves pathologic response (absence of cancer cells in tissue samples after treatment) in women with endometrial atypical hyperplasia/endometrial intraepithelial …
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a daily pill keep a rare heart disease in check for the long haul?
Disease control Not yet recruitingThe AG10-504 study is an open-label extension study of acoramidis in participants with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR-CM) or both ATTR-CM and transthyretin amyloid polyneuropathy (ATTR-PN).
Phase 3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC